HomeTOP STORIESEli Lilly outlines $80B–$83B 2026 revenue target amid robust incretin growth and... Eli Lilly outlines $80B–$83B 2026 revenue target amid robust incretin growth and new product launches By rogerjudd February 5, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleCoherent signals double-digit revenue growth for March and June quarters, eyes fiscal 2027 accelerationNext articleRegional Management targets 20%-25% net income growth and at least 10% receivables expansion in 2026 while advancing bank partnership strategy latest articles Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Rutgers research dean accused of secretly recording ‘upskirt’ videos with cellphone, prosecutors say explore more Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Idaho judge grants Bryan Kohberger two hearings next year as admitted killer seeks to withdraw guilty plea Rutgers research dean accused of secretly recording ‘upskirt’ videos with cellphone, prosecutors say
